3Bourbeau PP. Role of the microbiology laboratory in diagnosis and management of pharyngitis. J Clin Microbiol,2003,41:3467-3472.
4Kim S, Yong Lee N. Antibiotic resistance and genotypic characteristics of group A streptococci associated with acute pharyngitis in Korea. Microb Drug Resist,2004,10:300-305.
5Bisno AL, Gerber MA, Gwaitney JM, et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis.Clin Infect Dis, 2002,35:113-125.
6Pichicher ME. Sore throat after sore throat after sore throat:are you asking the critical questions? Postgrad Med, 1997,101:205-225.
7Felmingham D, Farrell DJ, Reinert RR, et al. Antibacterial resistance among children with community-acquired respiratory tract infections( PROTEKT 1999-2000 ). J Infect, 2004,48:39-55.
8Alos JI, Aracil B, Oteo JL, et al. Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype ) Streptococcus pyogenes in Spain. J Antimicrob Chemother,2003,51:333-337.
9Syrogiannopoulos G, Gfivea I, Fitoussi F, et al. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children.Pediatr Infect Dis J, 2001,20:863-868.
10Petinaki E, Kontos F, pratti A, et 81. Clinical isolates of maerolide-resistant Streptococcus pyogenes in Central Greece. Int J Antimierob Agents, 2003,21 : 67 -70.
5[4]Hirakata Y, Izumikawa K, Yamaguchi K, et al.Rapid detection and evolution of clinical characteristics of emerging multiple-drug-resistant Gram-negative rods carrying the metallo-β-lactamase gene blaIMP[J]. Antimicrob Agents Chemother, 1998, 42: 2006-2011.
6[5]Arakawa Y, Shibata N, Shibayama K, et al. Convenient test for screening metallo-β-lactamase-producing Gram-negative bacteria by using thiol compounds[J]. J Clin Microbiol, 2000, 38(1): 40-43.
7[6]National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard[S]. Fifth edition. Wayne Pennsylvania National Committee for Clinical Laboratory Standards. 2001.
8[7]Saino Y, Kobayash F, Inoue M, et al. Purification and properties of inducible penicillin-beta-lactamase isolates from Pseudomonas maltophilia[J]. Antimicrob Agents Chemother, 1982, 22: 564-570.
9[8]Senda K, Arakawa Y, Nakashima K, et al. Multifocal outbreaks of metallo-β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems[J]. Antimicrob Agents Chemother, 1996, 40(2): 349-353.
